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Abstract
Background: Tra1 is an essential protein in Saccharomyces cerevisiae. It was first identified in the SAGA and NuA4
complexes, both with functions in multiple aspects of gene regulation and DNA repair, and recently found in the
ASTRA complex. Tra1 belongs to the PIKK family of proteins with a C-terminal PI3K domain followed by a FATC
domain. Previously we found that mutation of leucine to alanine at position 3733 in the FATC domain of Tra1
(tra1-L3733A) results in transcriptional changes and slow growth under conditions of stress. To further define the
regulatory interactions of Tra1 we isolated extragenic suppressors of the tra1-L3733A allele.
Results: We screened for suppressors of the ethanol sensitivity caused by tra1-L3733A. Eleven extragenic recessive
mutations, belonging to three complementation groups, were identified that partially suppressed a subset of the
phenotypes caused by tra1-L3733A. Using whole genome sequencing we identified one of the mutations as an
opal mutation at tryptophan 165 of UPF1/NAM7. Partial suppression of the transcriptional defect resulting from
tra1-L3733A was observed at GAL10, but not at PHO5. Suppression was due to loss of nonsense mediated decay
(NMD) since deletion of any one of the three NMD surveillance components (upf1/nam7, upf2/nmd2,o rupf3)
mediated the effect. Deletion of upf1 suppressed a second FATC domain mutation, tra1-F3744A, as well as a
mutation to the PIK3 domain. In contrast, deletions of SAGA or NuA4 components were not suppressed.
Conclusions: We have demonstrated a genetic interaction between TRA1 and genes of the NMD pathway. The
suppression is specific for mutations in TRA1. Since NMD and Tra1 generally act reciprocally to control gene
expression, and the FATC domain mutations do not directly affect NMD, we suggest that suppression occurs as the
result of overlap and/or crosstalk in these two broad regulatory networks.
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Background
Tra1 is a 3744 amino acid residue protein, essential for
viability in Saccharomyces cerevisiae. It is a major constitu-
ent of the SAGA and NuA4 transcriptional regulatory
complexes [1-3], both with significant roles in gene regula-
tion and DNA repair [4-6]. More recently a putative com-
plex based on mutual associations termed ASTRA, was
also found to contain Tra1 [7]. Tra1’s mammalian homo-
log TRRAP was identified because of its interactions with
the transcription factors c-myc and E2F [8]. Similarly Tra1
interacts with yeast transcriptional activators to target
SAGA and NuA4 to promoters [9-12]. Interestingly,
Helmlinger et al. [13] have recently provided evidence that
Tra1 also acts independently of SAGA and NuA4 to regu-
late gene expression.
Tra1/TRRAP are members of the PIKK (phosphoinosi-
tide three-kinase-related kinase) family of proteins, a
group that in yeast includes Tor1, Tor2, Tel1 and Mec1
[14,15]. The latter two are structurally and functionally
related to ATM and ATR of multicellular eucaryotes.
Two additional family members not found in yeast, are
the DNA-PKcs (DNA-dependent protein kinase catalytic
subunit) and SMG-1, with key roles in DNA repair and
nonsense mediated decay of RNA, respectively. The
PIKK family members are all large proteins characterized
by a common arrangement of C-terminal domains [16],
including a domain that resembles the phosphatidylinosi-
tol-3-kinases (PI3K). Unlike the other PIKK molecules,
which are protein kinases, Tra1/TRRAP lacks kinase
activity [2,8]. Nonetheless, altering residues that parallel
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Tra1 function [17]. On the N-terminal side of the kinase
domain is the HEAT and TPR repeat-rich FAT (FRAP-
ATM-TRRAP) domain [18-21]. C-terminal to the PI3K
domain is the less highly conserved PRD (PIKK regula-
tory domain), identified in ATM as the site of acetylation
by TIP60 [22].
T h e~ 3 5 - r e s i d u eF A T Cd o m a i ni sa tt h ee x t r e m eC -
terminus of the PIKK proteins [18]. The critical role of
the FATC domain is evident from the finding that addi-
tion of a single glycine to the C-terminus of Tra1
abolishes function, and mutations of L3733 or F3744 to
alanine result in slow growth in a number of stress condi-
tions [23]. The FATC domain is similarly important for
the other PIKK family members; for example, the parallel
mutation to L3733A of Tra1 results in a dramatic loss in
the kinase activity of SMG-1 [24]. Dames et al. [25]
determined the structure of the isolated FATC domain of
S. cerevisiae Tor1. It is predominately helical with a loop
at the extreme C-terminus held in place by a disulphide
linkage. The helical structure is likely conserved in the
family, but not the loop because the two cysteines are
only found in the Tor proteins. FATC domains are pro-
posed to be a target for interacting proteins. In a two-
hybrid analysis the FATC domain of Mec1 was required
for association with the RPA components Rfa1 and Rfa2
[26]. In vivo, the FATC domain of ATM and Tip60 (the
mammalian homolog of the NuA4 component Esa1)
interact, though this may be indirect [22,27]. Consistent
with the mutagenesis analysis of Moritia et al. [24], Lem-
piäinen and Halazonetis [16] suggest the FATC domain
interacts with and regulates the activity of the kinase
domain.
Nonsense mediated decay (NMD) is a cellular surveil-
lance mechanism present in all eucaryotes that scans for
premature stop codons on mRNAs [28,29]. The process is
coupled to translation, and results in degradation of
potentially deleterious transcripts [30-32]. Premature stop
codons can arise through errors in transcription by RNA
Polymerase II, failure or inaccurate removal of introns,
inaccurate translational starts, ribosomal frameshifting,
RNA editing, or errors within the genomic DNA. The
mechanism of NMD varies in different organisms, with
the molecular details still being determined [33]. In yeast,
one model suggests that NMD is triggered if the mRNA
binding protein Hrp1 is bound to a downstream sequence
element(s) (DSE) when the ribosome encounters a stop
codon [34-36]. The DSE is 5’ of the native stop codon,
with Hrp1 normally being displaced by the passing ribo-
some. A second model, the faux (false) 3’ UTR model, pos-
tulates that the length of the 3’ untranslated region
resulting from a premature stop codon prevents the nor-
mal interactions that occur between the ribosome and
poly (A) binding protein during the termination of
translation. In the absence of these interactions the NMD
factors associate with the ribosome, which in turn results
in mRNA decay [37].
The yeast NMD surveillance complex consists of three
proteins, Upf1/Nam7, Upf2/Nmd2, and Upf3 (for simpli-
city referred to as Upf1, Upf2 and Upf3, respectively).
Mutations in any of the NMD proteins increase transla-
tional read-through and stabilize mRNA containing pre-
mature stop codons [30,38-43]. Upf1, an ATP dependent
RNA helicase [41,44] is the central component of the
pathway, whereas Upf2 and Upf3 regulate Upf1 [42,45]. In
metazoans, Upf1 is further regulated by phosphorylation/
dephosporylation [28]. The kinase involved is the PIKK
family member SMG-1 [45,46].
In addition to removing aberrant transcripts, the NMD
pathway plays a significant role in the control of gene
expression [47]. Microarray analyses indicate that approxi-
mately 10% of yeast genes are affected by loss of NMD;
most showing increased levels [48-50]. Approximately half
of the changes are the result of direct regulation by NMD
[50]. Some of the effects on translational readthrough are
due to increased expression of the magnesium transporter
Alr1p and the elevated cellular magnesium [51]. Other
regulatory functions may arise through programmed ribo-
somal frameshifting, and altered translational start site
selection [52-55].
To identify the genetic network in which Tra1 is
involved, we selected for second site suppressors that
allow growth of strains with the tra1-L3733A allele on
media containing ethanol. An opal mutation at codon 165
of upf1 was identified. Suppression was likely the result of
loss of NMD since deletion of upf1, upf2 or upf3 conferred
growth of strains containing tra1-L3733A. Suppression
was specific for mutations to TRA1; phenotypes arising
from deletions of SAGA or NuA4 components were not
suppressed. Since deletion of upf1 only reversed the tran-
scriptional defects of the tra1 alleles at a subset of affected
promoters, and these same tra1 alleles did not affect
NMD, we conclude that loss of NMD suppresses the
TRA1 mutations through crosstalk and/or partial overlap
of their regulatory networks.
Results
The FATC domain of Tra1 is critical to the protein’s
function. Mutation of leucine 3733 to alanine results in
temperature sensitivity and slow growth in media con-
taining ethanol, Calcofluor white or rapamycin [23].
T h e s ep h e n o t y p e sp r o v i d eat o o lt op r o b et h eg e n e t i c
network in which TRA1 is connected. We selected for
extragenic suppressors of the ethanol sensitivity of
CY4018, a strain disrupted for the genomic tra1 but
viable due to tra1-L3733A on a URA3 centromeric plas-
mid. Approximately 10
8 cells were plated onto YPD
plates containing 4% ethanol. Forty-three colonies were
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Page 2 of 13isolated for further analysis. Each was retested for the
suppression after colony isolation, and then examined for
whether the mutation was located on the tra1-L3733A
containing-plasmid by plasmid shuffling. Eleven strains
with extragenic mutations that partially suppressed the
slow growth due to tra1-L3733A were identified. The
growth of these strains on YPD media and YPD contain-
ing 4% ethanol is shown in Figure 1a. The strains with
the tra1-L3733A suppressor alleles (tentatively termed
es2, es12, es35 etc.) were mated with the MATa tra1-
L3733A strain CY5522 to determine if the suppressor
mutations were dominant or recessive. Figure 1b shows
the analysis for CY5579 (es2), CY5584 (es38), and
CY5587 (es41). The diploid strains grew slowly under
selective conditions, indicating that the suppressor alleles
act recessively. Similarly each of the additional es alleles
was recessive. Complementation groups were analyzed
through crosses of the es containing strains. As shown in
Figure 1c, the diploid crosses of es2 with es38,a n des41,
grew poorly on media containing 4% ethanol, in contrast
to the homozygous diploid containing es2.I nt h i sw a y
three complementation groups were identified amongst
the eleven strains isolated in the screen. One comple-
mentation group contained uniquely es2; a second group
contained uniquely es35. The third complementation
group contained the remaining nine alleles, including
es38 and es41. A random spore analysis indicated that
the ethanol resistance for the es2, es35 and es38 strains
(representing each complementation group) segregated
2:2 suggesting that a single gene was the cause of
suppression.
To determine the identity of the suppressor alleles for
the es2 and es38/es41 complementation groups, we com-
pared the genome sequence for each of the three strains
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WT/WT 
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Figure 1 Extragenic suppression of tra1-L3733A.A .C Y 4 0 1 8( tra1-L3733A, LA) was plated onto YPD media containing 4% ethanol (EtOH) at
30°C. Growing colonies were in succession: colony purified on media containing ethanol, plated on YPD at 30°C, and retested on media
containing ethanol. The 11 strains passing this selection (CY5579, es2; CY5580, es12; CY5581, es35; etc.), CY2706 (TRA1), and CY4018 (tra1-L3733A)
were grown to stationary phase, serially diluted and plated onto YPD or YPD containing 4% ethanol at 30°C. B. The es2, es38 and es41 alleles are
recessive. Strains CY5579 (es2 tra1-L3733A), CY5584 (es38 tra1-L3733A) and CY5587 (es41 tra1-L3733A) were mated with CY5522 (tra1-L3733A)t o
generate diploid strains homozygous for tra1-L3733A and heterozygous for each suppressor. Serial dilutions of these strains as well as the diploid
wild-type strain CY5557 and the homozygous tra1-L3733A strain CY5558 were spotted onto the indicated plates. C. es2 forms an independent
complementation group. Serial dilutions of diploid strains arising from crosses of haploid strains CY5579 with CY5522 (es2 x ES2), CY5579 with
CY5666 (es2 x es2), CY5666 with CY5584 (es2 x es38), and CY5666 with CY5587 (es2 x es41) were spotted onto the indicated plates.
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Page 3 of 13relative to the parent CY4018. (The third complementa-
tion group was not analyzed.) Libraries were prepared and
genomic sequencing performed using the ABI SOLiD 4.0
platform at the Centre for Applied Genomics at The Hos-
pital for Sick Children (Toronto, Canada). Approximately
50 million reads were obtained for each sample of which
60% mapped to the reference genome from the Saccharo-
myces Genome Database. Polymorphisms not found in
CY4018 or the other complementation group, were ana-
lyzed by visual inspection of the sequencing reads. A cau-
sative mutation could not be identified within coding or
noncoding sequences for the es38/es41 complementation
group. The es2 strain contained an opal mutation at tryp-
tophan codon 165 of UPF1, truncating the 971-residue
protein. To confirm that this allele, now designated upf11-
164, was responsible for the suppression of tra1-L3733A,
CY5579 (upf11-164 tra1-L3733A) was mated with CY4018
(tra1-L3733A), sporulated, and the UPF1 alleles in 8 unre-
lated spore colonies, four exhibiting slow growth and four
fast growth, were isolated by PCR and sequenced. The
four spore colonies growing slowly on 4% ethanol con-
tained wild-type UPF1, whereas the fast growing spore
colonies contained upf11-164.
In S. cerevisiae, Upf1 is one of three proteins acting in
the NMD surveillance complex, the others being Upf2
a n dU p f 3 .T od e t e r m i n ei fl o s so ft h i sp r o c e s sw a s
responsible for suppression of tra1-L3733A,w ea n a l y z e d
the growth of strains deleted for upf1, upf2 or upf3 in
media containing 6% ethanol and at 37°C. As shown in
Figure 2A, deletion of any of the components of the
NMD surveillance complex partially suppressed the slow
growth due to tra1-L3733A. Though not documented as
at a r g e to fN M D ,i ti sp o s s i b l et h a tl o s so fN M Ds u p -
presses the tra1-L3733A allele by increasing the cellular
concentration of the protein. We therefore constructed
strains that contain an integrated copy of Flag
5-tagged
Tra1 or Tra1-L3733A, and examined expression in the
presence or absence of upf1 by Western blotting of cell
extracts (Figure 2B). The expression of the integrated
Flag
5-Tra1-L3733A is similar to the wild-type protein
(compare lanes 1 and 3). Disruption of upf1 slightly
increased expression of Tra1-L3733A (compare lanes 3
and 6). We estimate this increase to be less than 10%,
and suggest that it is not sufficient to account for the
suppression.
We next addressed the allele specificity of the suppres-
sion. Alteration of the terminal phenylalanine of tra1 to
alanine results in slow growth in media containing etha-
nol. A strain deleted for upf1 and containing tra1-
F3744A was constructed and its growth compared to the
single mutant strains (Figure 3a). Deletion of upf1 sup-
pressed the slow growth due to tra1-F3744A,a tl e a s tt o
the same extent as for tra1-L3733A. Deletion of upf1 also
suppressed slow growth at 37°C and on media containing
6% ethanol caused by tra1-SRR3413, a triple alanine
scanning mutation to residues 3,413-3,415 within the
PI3K domain ([17]; Figure 3b). Deletions of other compo-
nents of the SAGA and NuA4 complexes were then
examined (Figure 3c and 3d). Deletion of ada2 results in
slow growth on media containing ethanol; however,
unlike the tra1 mutations, the slow growth caused by
ada2Δ was not suppressed by upf1Δ (Figure 3c). Disrupt-
ing the NuA4 components Eaf3 or Eaf7 results in slow
growth at 35°C in media containing 6% ethanol. Deletion
WT
tra1-L3733A
L3733A upf1Δ
TRA1 upf1Δ
TRA1 upf3Δ
L3733A upf3Δ
TRA1 upf2Δ
L3733A upf2Δ
37r 6% EtOH  YPD 
α Flag
CBB 
Flag5-Tra1 
Upf1 
μg
1      2      3      4     5     6      7      8 
A B 
na WT LA LA LA LA LA LA
WT WT WT WT WT ΔΔΔ
25 25 25 50 50 50 12.5 12.5
Figure 2 Deletions of components of the NMD pathway suppress tra1-L3733A. A. Haploid strains CY4353 (TRA1 UPF1), CY4103 (tra1-L3733A
UPF1), CY5932 (TRA1 upf1Δ), CY5972 (tra1-L3733A upf1Δ), CY5936 (TRA1 upf3Δ), CY5983 (tra1-L3733A upf3Δ), CY5934 (TRA1 upf2Δ), and CY5996 (tra1-
L3733A upf2Δ) were grown in YPD media to stationary phase, and 10-fold serial dilutions plated onto YPD, YPD containing 6% ethanol, or YPD
grown at 37°C. B. Expression of Flag
5-Tra1-L3733A. Yeast strains CY5940 (Flag
5-TRA1; lane 1), CY6004 (Flag
5-tra1-L3733A; lanes 2-4), CY6005 (Flag
5-
tra1-L3733A upf1Δ0; lanes 5-7) and BY4741 (TRA1, not applicable; lane 8) were grown to stationary phase then diluted 1:20 into YPD and grown
for 8 hours at 30°C. Protein extracts were prepared by lysis with glass beads. The indicated amount of protein was separated by SDS-PAGE (5%)
and either Western blotted with anti-Flag antibody or stained with Coomassie Brilliant Blue (CBB).
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F3744A UPF1
F3744A upf1Δ
TRA1 upf1Δ
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ADA2 upf1Δ
ada2Δ upf1Δ
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Figure 3 Suppression by upf1Δ is specific for mutations within the FATC domain of Tra1. A. upf1Δ suppression of tra1-F3744A.S e r i a l
dilutions of CY4353 (TRA1 UPF1), CY4350 (tra1-F3744A UPF1), CY5932 (TRA1 upf1Δ), and CY6030 (tra1-F3744A upf1Δ) were spotted onto YPD at 30°
C or 37°C, or YPD containing 6% ethanol at 30°C. B. upf1Δ suppression of tra1-SRR3413. Serial dilutions of BY4742 (TRA1 UPF1), CY5932 (TRA1
upf1Δ), CY2200 (tra1-SRR3413 UPF1), and CY6111 (tra1-SRR3413 upf1Δ) were spotted onto YPD at 30°C or 37°C, or YPD containing 6% ethanol at
30°C. C. upf1Δ does not suppress ada2Δ. Serial dilutions of CY4353 (ADA2 UPF1), BY4282 (ada2Δ UPF1), CY5932 (ADA2 upf1Δ), and CY5979 (ada2Δ
upf1Δ) haploids were spotted onto the indicated YPD plates. D. upf1Δ does not suppress eaf3Δ or eaf7Δ. Serial dilutions of CY4353 (WT), CY5932
(upf1Δ), BY7143 (eaf3Δ UPF1), CY5980 (eaf3Δ upf1Δ), BY2940 (eaf7Δ UPF1), and CY5976 (eaf7Δ upf1Δ) haploids were spotted onto YPD at 30°C or
YPD containing 6% at 35°C.
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Page 5 of 13of upf1 did not suppress this phenotype for either the
eaf3Δ or eaf7Δ strains (Figure 3d). In fact synthetic slow
growth was observed on plates containing 6% ethanol for
the double mutant strains. This latter result agrees with
the synthetic slow growth reported for mutations of esa1
and eaf7 with upf1 and upf3, respectively [56,57].
Alterations to the FATC domain cause slow growth in a
number of conditions [23]. We analyzed which of these in
addition to the suppression of ethanol and temperature
sensitivity are suppressed by upf1Δ. As shown in Figure 4,
deletion of upf1 suppressed the slow growth resulting
from tra1-F3744A when galactose is the carbon source,
when phosphate is depleted, and when phleomycin (a
DNA damaging agent) is present in the media. In contrast
deletion of upf1 did not suppress slow growth due to tra1-
F3744A in the presence of the cell wall destabilizing agent
Calcofluor white, and only had a modest effect with rapa-
mycin. The latter was particularly interestingly, given that
deletion of upf1 in the wild-type TRA1 background
decreased sensitivity to rapamycin (compare TRA1 UPF1
with TRA1 upf1Δ).
We next addressed whether disruption of upf1 would
reverse the transcriptional defects caused by the TRA1
mutations. Expression of two lacZ promoter fusions was
examined: PHO5-lacZ and GAL10-lacZ. tral-L3733A and
tra1-F3744A decreased activated expression of PHO5-
lacZ to approximately one-third of the wild-type level
(Figure 5a). Interestingly, the strain containing a disrup-
tion of upf1 in the context of wild-type TRA1 also
showed decreased expression (approximately 2-fold).
Furthermore, disruption of upf1 in the context of either
tral-L3733A or tra1-F3744A did not restore transcrip-
tion. As shown in Figure 5b expression of GAL10-lacZ
was also reduced by tral-L3733A and tra1-F3744A,b u t
in contrast to PHO5-lacZ not by deletion of upf1.I n
addition, at GAL10 the transcriptional defect due to the
tral alleles was partially reversed by upf1Δ.T o g e t h e r
these results suggest that in some, but not all, cases dis-
ruption of upf1 may suppress tra1-induced phenotypes
by regulating transcription (most likely indirectly) of
common genes.
Our previous studies with TRA1 have linked phenotypes
resulting from its mutation with transcriptional change
[17,23]. The observation that disrupting upf1 did not
restore transcription in all cases, suggested two models for
how loss of NMD might suppress the FATC domain
mutations. The first predicts a direct link between NMD
and Tra1. If Tra1 is a negative regulator of NMD, Tra1-
L3733A might increase NMD, decreasing the level of
certain mRNA transcripts, which in turn could cause
growth-related phenotypes. Loss of the NMD pathway
would reverse the effect. The interaction between SAGA
component Sgf29 and Upf1 [58], and the phosphorylation
of Upf1 by the PIKK member SMG-1 in metazoans
[45,46,59], are consistent with the possibility of direct reg-
ulation. The second model predicts a less specific interac-
tion between Tra1 and NMD. The tra1 mutations through
its action in SAGA, NuA4 or independently [13] alter
expression of a set of genes. Some of these genes, or genes
with epistatic relationships, may be regulated through
mRNA turnover and/or translational readthrough by pro-
cesses involving NMD. This possibility is enhanced by the
scope of both networks and their generally reciprocal nat-
ure. By eliminating NMD the expression of genes that
directly or indirectly intersect in the pathways may return
to near normal, effectively compensating for diminished
Tra1 activity. To differentiate between these models, we
analyzed whether tral-L3733A alters NMD. We con-
structed a PGK1-lacZ fusion (PGK1fs-lacZ; Figure 6a) fra-
m e s h i f t e da tc o d o n1 6 6a n di n c l u d i n gt h o s es e q u e n c e s
required for NMD, -544 to 891 [34,60]. Previous mRNA-
seq experiments have indicated that PGK1 expression in
YPD media is relatively unaffected by mutations within
the FATC domain of Tra1 [23]. Deletion of upf1 results in
a 5-fold increase in expression of b-galactosidase from the
PGK1fs-lacZ fusion in comparisont oaw i l d - t y p eUPF1
strain (Figure 6b), verifying the use of this construct to
monitor NMD. Indicative of Tra1 not having a direct role
TRA1 UPF1 
F3744A UPF1 
F3744A upf1Δ 
YPD  Phleomycin  Galactose  Rapamycin  Phosphate- 
Calcofluor  
white 
TRA1 upf1Δ 
Figure 4 Phenotypes of TRA1-F3744A suppressed by upf1Δ. Serial dilutions of yeast strains CY4353 (TRA1 UPF1), CY4350 (tra1-F3744A UPF1),
CY5932 (TRA1 upf1Δ), and CY6030 (tra1-F3744A upf1Δ) haploids were spotted onto YPD, YP plus 2% galactose, YPD depleted of phosphate, or
YPD containing 1 μg/mL phleomycin, 10 μg/mL Calcofluor white, or 2 nM rapamycin.
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Page 6 of 13in NMD, expression of PGK1fs-lacZ was unaffected by
tral-L3733A. In light of this result and the broad role for
NMD in gene expression, we thus favor a model whereby
deletion of NMD suppresses the tra1 alleles through its
reciprocal action on an overlapping set of genes.
Discussion
We have identified a genetic interaction between compo-
nents of the nonsense mediated decay pathway and tra1,
through random selection for mutations that suppress the
ethanol sensitivity of a tra1-L3733A strain. Our initial
selection identified a nonsense mutation at codon 165 of
UPF1. Similar suppression was found with deletions of
upf1, upf2 and upf3 indicating that loss of nonsense
mediated decay was the likely cause. Our study demon-
strates a relationship between the Tra1 and NMD
regulatory networks, and further emphasizes the general
importance of NMD in gene expression.
The suppression mediated by deletion of upf1 was speci-
fic for certain phenotypes arising from tra1 mutations.
Slow growth due to high temperature, ethanol, low phos-
phate, galactose as the primary carbon source, and phleo-
mycin was suppressed. Slow growth due to rapamycin or
Calcofluor white was not. The suppression mediated by
upf1Δ was also specific for mutations within TRA1,n o t
suppressing deletions of the SAGA component Ada2 or
the NuA4 components Eaf3 or Eaf7. In the case of the lat-
ter two disruptions, synthetic slow growth was observed.
We propose the suppression of tra1-L3733A and tra1-
F3744A caused by loss of NMD is the result of crosstalk
and/or direct overlap in the networks regulated by these
genes. In this model, altered (most often decreased)
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Figure 5 Expression of PHO5-lacZ and GAL10-lacZ in upf1Δ strains. A. Yeast strains CY4353 (TRA1 UPF1), CY5932 (TRA1 upf1Δ), CY4103 (tra1-
L3733A UPF1), CY5972 (tra1-L3733A upf1Δ), CY4350 (tra1-F3744A UPF1), and CY6030 (tra1-F3744A upf1Δ) were transformed with a LEU2
centromeric plasmid containing a PHO5-lacZ fusion, grown to stationary phase in media depleted of leucine, washed three-times with water,
diluted into YPD media depleted of phosphate, grown for 16 hr at 30°C and b-galactosidase activity determined, normalizing to cell density. B.
GAL10-lacZ was analyzed as above with initial cultures grown in raffinose containing media and shifting to 2% galactose. The P values for the
statistical significance of the difference of UPF1 versus upf1Δ for TRA1-L3733A and tra1-F3744A are 0.006 and 0.001 (n = 6), respectively.
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Figure 6 Expression of frameshifted PGK1 in tra1-L3733A and tra1-F3744A strains. A. PGK1fs-lacZ. The promoter and coding reading of
PGK1 from-544 to 891 was synthesized by PCR, and the reading frame changed after codon 166 by endfilling of the Asp718 site (493 bp, solid
line) and religation. This results in a stop 26 codons 3’ to the frameshift (asterick). PGK1 is fused to residues 305-403 of HIS3 (white box) followed
by the coding sequence of lacZ. B. Yeast strains CY4353 (TRA1 UPF1), CY5932 (TRA1 upf1Δ), CY4103 (tra1-L3733A UPF1), and CY5972 (tra1-L3733A
upf1Δ) were transformed with a LEU2 centromeric plasmid containing PGK1fs-lacZ. Cultures were grown to stationary phase in media depleted of
leucine, inoculated at a 100-fold dilution in YPD media, grown for 16 hr at 30°C and b-galactosidase activity determined, normalizing to cell
density.
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partially reversed by reducing mRNA turnover (or enhan-
cing translational readthrough) in the NMD deficient
backgrounds. Also along this line, a gene regulated by
NMD may encode a protein that directly or indirectly reg-
ulates some of the functions of Tra1. Our reasons for pre-
ferring this indirect mechanism for suppression are the
following. First, consistent with this model nonsense
mediated decay has a broad role in gene regulation. Some
of NMD’s roles relate to the removal of aberrant tran-
scripts that have acquired nonsense codons. Other roles
relate to control mechanisms that utilize the pathway to
remove mRNAs that would otherwise be functional. As
such NMD influences approximately 10% of yeast genes
[48,49]–likely an underestimate of the extent of its control
as this is in rich media. Clearly the breadth of the NMD
effect indicates that NMD is of global importance in yeast
regulatory pathways, not only affecting aberrant tran-
scripts. The majority of genes are upregulated in response
to loss of NMD; this contrasts to the generally more pre-
valent decreased expression observed upon mutation of
tra1 [17,23]. Thus the prevalence of genes affected and
reciprocal nature of loss of NMD and Tra1 could result in
their neutralization in a double mutant background.
Indeed, it is the scope of NMD that likely explains why its
loss can also suppress mutations of other globally impor-
tant yet functionally diverse factors required for gene
expression (for example: TAF6, TAF9 and RAP1 [57],
PAF1 [61], and BRE1 [62]).
This indirect model for suppression accommodates the
finding that only a subset of tra1-L3733A phenotypes is
suppressed by loss of NMD. Suppression would require
that Tra1 and NMD regulate key genes responsible for the
phenotype (also see below). Similarly, specificity for TRA1
mutations may be accounted for if other NuA4 and/or
SAGA components influence genes to an extent that is
not sufficiently reversed by NMD. Finally, the finding that
loss of NMD affects promoter-dependent events of some
tra1-effected genes (for example GAL10)b u tn o to t h e r s
(for example, PHO5) is more consistent with an indirect
mechanism for suppression that could act through distinct
genes and/or steps in gene expression, rather than by
restoring Tra1 function.
Alternative models for suppression by upf1Δ are possible
if Tra1 were involved in NMD. The finding that tra1-
L3733A and tra1-F3744A did not alter expression of an
internally frame-shifted PGK1 reporter plasmid, suggests
that Tra1 is not directly involved in NMD. The lack of
direct relationship between Tra1 and NMD is consistent
with Tra1 acting in the nucleus, whereas in S. cerevisiae
NMD is primarily a cytoplasmic process regulating post-
transcriptional events [63].
We have not pinpointed the genes whose regulation by
NMD allows suppression of the phenotypes caused by
tra1-L3733A. Because of epistatic relationships, the key
genes affected by tra1-L3733A and NMD may not be
identical. It is also possible that small changes in multiple
target genes could cause suppression; this would make
identification of relevant targets difficult. Expression
screening of mRNAs to detect changes in profiles may be
complicated because the genes are likely stress induced,
and will differ from condition to condition. Moreover,
some aspects of NMD relate specifically to translation,
and will not be seen by RNA profiling. Nonetheless,
we have compared gene expression profiles in YPD
media for tra1-L3733A [23] and upf1Δ [49] strains. Of
the 79 genes with reduced expression due to tra1-
L3733A (twofold or greater), six display increased expres-
sion of twofold or greater with upf1Δ (one has decreased
expression). This ratio, given that it approximates the
10% of the genome regulated by NMD, does not support
a specific overlap in the pathways, however it does
emphasize the generally reciprocal nature of Tra1 and
NMD. The six genes with reciprocal changes in expres-
sion are YBL107C, YER187W, MIP6 (YHR015W), JMN1
(YMR294W), YNR071C and YOL014W. Of these only
MIP6 and JMN1 have characterized functions. MIP6 is of
potential relevance since it encodes a protein with puta-
tive RNA binding motifs, and was identified in a two-
hybrid analysis as interacting with the Mex67, an mRNA
export factor [64].
When expressed on a centromeric plasmid from the
DED1 promoter, Tra1-L3733A is less abundant than the
wild type protein [23]. We do not observe this decrease
when FATC mutations are integrated into the genome.
For this reason the functional experiments performed in
this analysis were with genomically encoded tra1-L3733A
and tra1-F3744A. Based on the recent results of Stirling et
al. [65], who show a link between chromosome instability
and components of the ASTRA complex, we believe that
t h ep l a s m i dv e r s i o n sm a yb el e s sw e l le x p r e s s e dd u et o
decreased stability of the plasmid for the mutant versions
of tra1.
In a recent independent selection for suppressors of
tra1-F3744A, we identified two alleles of the ASTRA com-
ponent Tti2 (Genereaux et al. Genetics, in press). The tti2
alleles also suppress tra1-L3733A, but not deletions of
components of SAGA or NuA4 components. The tti2
alleles, unlike upf11-164, acted dominantly. This as well as
complementation experiments with TTI2 (not shown)
suggests that es38/41 and es35 represent additional inde-
pendent suppressor alleles.
Conclusion
We have demonstrated a genetic interaction between
TRA1 and genes of the nonsense mediated decay path-
way. In a recessive manner, deletion of upf1 partially
suppressed the growth related defects of tra1-L3733A,
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Page 8 of 13tra1-F3744A and tra1-SRR3413, mutations within the
FATC and PI3K domains. The suppression was specific
for TRA1 mutations; no effect was seen for deletions of
other SAGA or NuA4 components. A subset of pheno-
types attributable to the FATC mutations was sup-
pressed; furthermore, not all transcriptional defects were
reversed by deletion of upf1. We suggest that the
suppression relates to the breadth and overlapping, yet
generally reciprocal nature of the gene regulatory path-
ways in which Tra1 and the NMD components are
involved.
Methods
Yeast strains and growth
Strains for selection of suppressor mutations are deriva-
tives of KY320 ([66]; see Table 1) and the isogenic MATa
strain CY4413. CY1021 contains a genomic disruption of
tra1 and is maintained by a plasmid copy of myc-tagged
TRA1 expressed from the DED1 promoter [2]. CY3003
[23] and CY4018 were obtained from CY1021 by plasmid
shuffling and contain myc
9-tagged tra1-L3733A expressed
from the DED1 promoter on YCplac22 [67] or a URA3
centromeric plasmid (YCplac22u) derived from YCplac22
by switching TRP1 to URA3, respectively [68]. CY5522 is
the MATa equivalent of CY4018 and was generated by
mating CY4413 with CY4018. After sporulation, a MATa
spore colony was isolated that required the plasmid copy
of tra1-L3733A for growth. Strains carrying tra1-L3733A
and extragenic suppressors (hereafter defined as es alleles)
es2 (CY5579), es12 (CY5580), es35 (CY5581), es36
(CY5582), es37 (CY5583), es38 (CY5584), es39 (CY5585),
es40 (CY5586), es41 (CY5587), es42 (CY5588), and es43
(CY5750) were derived from CY4018 using the selection
scheme described below. CY5666 (es2), CY5758 (es38),
and CY5603 (es41)a r eMATa equivalents of CY5579,
CY5584, and CY5587, respectively, and were made after
mating with CY5522. MATa spore colonies carrying the
suppressor were selected based on their ability to grow at
high temperature and on plates containing 4% ethanol.
Yeast strains deleted for upf1 (CY5932), upf3 (CY5936)
and upf2 (CY5934) were derived from the diploid strains,
BY46214, BY44702 and BY41905 [71], respectively, by
selecting Kan
r spore colonies. These MATa strains were
mated with CY4057 (tra1-L3733A; [23]), to yield after
sporulation and selection of Kan
r His
- spore colonies
CY5972 (upf1Δ tra1-L3733A), CY5983 (upf3Δ tra1-
L3733A), and CY5996 (upf2Δ tra1-L3733A). Similarly,
CY6030 (upf1Δ tra1-F3744A) was generated after mating
of CY4351 (tra1-F3744A) and CY5932. CY5939 (upf1Δ::
nat1) was obtained by gene replacement of Kan
r with
nat1. Double mutant strains of upf1Δ::nat1 with ada2Δ
(CY5979), eaf3Δ (CY5980), and eaf7Δ (CY5976) were
obtained after mating and sporulation of the diploids of
crosses of CY5939 with BY4282, BY7143, and BY2940,
respectively. CY6111 (tra1-SRR3413 upf1Δ)w a sd e r i v e d
after mating of CY2220 [69] and CY5932, and selecting
Ura + Kan
r spore colonies. CY6004, CY6005 contain a
TRA1 allele with a N-terminal Flag
5-tag integrated with a
URA3 marker.
Growth comparisons were performed on YP media con-
taining 2% glucose (YPD) selective plates after 3-5 days at
30°C unless stated otherwise. Standard concentrations
used for the selections are as follows: 7.5 μg/ml Calcofluor
White (Sigma-Aldrich, Inc.), 4% or 6% ethanol, 1.0 μg/ml
phleomycin (Sigma-Aldrich, Inc.), and 2 nM rapamycin
(LC Laboratories, Woburn Ma). We note that the KY320
background is more sensitive to ethanol than the BY4741
background, accounting for the use of either 4% or 6%
ethanol, respectively.
DNA molecules
Myc-tagged tra1 alleles on the centromeric TRP1
(YCplac22) or URA3 (YCplac33) plasmids have been
described [17,23]. PHO5 (-452 to +47) and GAL10 (-595
to -245) promoter-lacZ fusions in the LEU2 centromeric
plasmid YCp87 have been described [17,72]. The PGK1-
lacZ fusion with a frameshift mutation (PGK1fs-lacZ)
was constructed by synthesizing the gene from -544 to
+891 by PCR using oligonucleotides 5’-GCGGATC-
CACGTGGCCTCTTATCGAG-3’ and 5’-CTCAAGCT
TCCTTGGTGTTGGCATCAGCAGAG-3’, digesting the
gene with Asp718, creating blunt ends with the Klenow
fragment of DNA polymerase and religation.
Isolation of suppressor strains
Six cultures of CY4018 were grown overnight in YPD.
Approximately 100 million cells were plated onto 200
YPD plates containing 4% ethanol and incubated at 30°C
for 5 days. Fast growing colonies were colony purified and
retested. YCplac22-tra1-L3733A was transformed into
each potential suppressor strain and YCplac22u-myc9-
tra1-L3733A shuffled out on 5-fluoroorotic acid. Strains
that retained their ability to grow on 4% ethanol were
defined as containing extragenic suppressors.
Genomic sequence analysis
Genomic DNA was prepared from10 mL of lyticase treated
cells [73]. Approximately 5 μg of DNA from each sample
was sent to the Centre for Applied Genomics (Toronto,
Ontario). DNA library construction and next-generation
sequencing using paired-end reads was performed at the
Centre. Samples were sequenced using the Applied Biosys-
tems SOLiD 4.0 next-generation sequencing platform. The
sequencing was performed in a single lane with multiplex-
ing that included 11 additional unrelated samples. The Sac-
charomyces cerevisiae genome sequence was downloaded
from the Saccharomyces Genome Database (SGD; [74]) on
March 24, 2011. Custom Shell and Perl scripts were
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Strain
number
Description TRA1 plasmid Reference
CY1021 Isogenic to KY320 except tra1Δ YCplac22-myc-TRA1 [2]
CY2706 Isogenic to CY1021 YCplac22-myc9-TRA1 [23]
CY3003 Isogenic to CY1021 YCplac22-myc9-tra1-
L3733A
[23]
CY4018 Isogenic to CY1021 YCplac22u-myc9-tra1-
L3733A
This study
CY5522 Isogenic to CY3003 except MATa YCplac22-myc9-tra1-
L3733A
This study
CY5557 Diploid cross of CY2706 and CY4413 YCplac22-myc9-TRA1 This study
CY5558 Diploid cross of CY4018 and CY5522 YCplac22-myc9-tra1-
L3733A
This study
CY5579 isogenic to CY4018 except es2 (upf11-164) YCplac22u-myc9-tra1-
L3733A
This study
CY5580 isogenic to CY4018 except es12 YCplac22u myc9-tra1-
L3733A
This study
CY5581 isogenic to CY4018 except es35 YCplac22u myc9-tra1-
L3733A
This study
CY5582 isogenic to CY4018 except es36 YCplac22u myc9-tra1-
L3733A
This study
CY5583 isogenic to CY4018 except es37 YCplac22u myc9-tra1-
L3733A
This study
CY5584 isogenic to CY4018 except es38 YCplac22u myc9-tra1-
L3733A
This study
CY5585 isogenic to CY4018 except es39 YCplac22u-myc9-tra1-
L3733A
This study
CY5586 isogenic to CY4018 except es40 YCplac22u-myc9-tra1-
L3733A
This study
CY5587 isogenic to CY4018 except es41 YCplac22u-myc9-tra1-
L3733A
This study
CY5588 isogenic to CY4018 except es42 YCplac22u-myc9-tra1-
L3733A
This study
CY5750 isogenic to CY4018 except es43 YCplac22u-myc9-tra1-
L3733A
This study
CY5666 Isogenic to CY5522 except es2 (upf11-164) YCplac22-myc9-tra1-
L3733A
This study
CY5758 Isogenic to CY5522 except es38 YCplac22-myc9-tra1-
L3733A
This study
CY5603 Isogenic to CY5522 except es41 YCplac22-myc9-tra1-
L3733A
This study
CY5688 Isogenic to CY2706 except es2 (upf11-164) YCplac22u-myc9-TRA1 This study
CY5690 Isogenic to CY2706 except es38 YCplac22u-myc9-TRA1 This study
CY5691 Isogenic to CY2706 except es41 YCplac22u-myc9-TRA1 This study
KY320 MATa ura3-52 ade2-101 trp1-Δ1 lys2-801 his3-Δ200 leu2::PET56 [66]
CY4413 MATa ura3-52 ade2-101 trp1-Δ1 lys2-801 his3-Δ200 leu2::PET56
CY2222 MATa can1Δ::STE2pr-SpHIS5 lyp1Δ his3Δ 1 leu2Δ0 ura3Δ0 met10 LYS2+ TRA1-SRR3413-URA3 [69]
BY4741 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 [70]
BY4742 MATa his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0 [70]
BY2940 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 eaf7::KanMX [70]
BY4282 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 ada2::KanMX [70]
BY7143 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 eaf3::KanMX [70]
BY41905 MATa/a his3Δ1/his3Δ1 leu2Δ0 lys2Δ0/LYS2 MET15/met15Δ0 ura3Δ0/ura3Δ0 + can1Δ::LEU2 + -MFA1pr-
HIS3/CAN1+ upf2Δ::KanMX
[71]
BY44702 MATa/a his3Δ1/his3Δ1 leu2Δ0 lys2Δ0/LYS2 MET15/met15Δ0 ura3Δ0/ura3Δ0 can1Δ::LEU2 + -MFA1pr-
HIS3/CAN1+ upf3Δ::KanMX
[71]
BY46214 MATa/a his3Δ1/his3Δ1 leu2Δ0 lys2Δ0/LYS2 MET15/met15Δ0 ura3Δ0/ura3Δ0 can1Δ::LEU2 + -MFA1pr-
HIS3/CAN1+ upf1Δ::KanMX
[71]
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Page 10 of 13written for the sequencing analysis. The program Bowtie
[75], allowing up to three mismatches per read, was used
to map the colorspace reads to each chromosome of the
yeast genome and obtain mapped reads in SAM format
(Sequence Alignment/Map; [76]). The VCF (variant call
format) from SAMtools [76] was used to obtain a raw list
of polymorphisms from the mapped reads. Those reads
with a Phred quality score below 20 were eliminated to
obtain a filtered list of polymorphisms. A custom Perl
script was written to eliminate the background polymorph-
isms found in wild-type samples.
b-galactosidase assays
Yeast strains containing lacZ-promoter fusions were
grown to stationary phase in media lacking leucine.
Assays with PHO5-lacZ in media depleted of phosphate
and GAL10-lacZ in media containing galactose as the
sole carbon source were performed as described in
Mutiu et al. [17] and Brandl et al. [72], respectively,
with ο-nitrophenol-b-D-galactosidase as substrate and
normalizing values to cell density. Assay of PGK1fs-lacZ
was performed similarly in YPD media. Results pre-
sented are from a minimum of four replicates with the
standard errors indicated.
Western blotting
Western blotting was performed using PVDF mem-
branes and anti-Flag (M2; Sigma-Aldrich) antibody as
described previously [17].
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